Ubrogepant
CAS: 1374248-77-7
Ref. TM-T17194
1mg | 150.00 € | ||
5mg | 369.00 € | ||
10mg | 583.00 € | ||
25mg | 914.00 € | ||
50mg | 1,198.00 € | ||
100mg | 1,643.00 € | ||
1mL*10mM (DMSO) | 484.00 € |
Product Information
- MK-1602
- Ubrelvy
- Spiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1′,2′,5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxo-, (3′S)-
- (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
- MK 1602
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies.
Chemical properties
Technical inquiry about: TM-T17194 Ubrogepant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.